US OptionsDetailed Quotes

AGIO250117P35000

Watchlist

2.50
-0.45-15.25%

15min DelayClose Jan 17 16:00 ET

2.70High2.50Low

Agios Pharmaceuticals Stock Discussion

Meltyy

Aug 6, 2024 02:59

📅 FDA PDUFA Update…

🚨 This Week’s PDUFA:
$Humacyte (HUMA.US)$ : 🤔
⇨ Human Acellular Vessel (HAV)™
‣ Vascular Trauma
‣ PDUFA: 8/10/24 (BLA)
🗓️ Last Week’s AdCom & PDUFAs:
$Zevra Therapeutics (ZVRA.US)$ : Favorable AdCom 👍
🗳️ 11-5 votes in favor
⇨ Arimoclomol
‣ Niemann-Pick disease type C
‣ AdCom: 8/2/24 (NDA)
$Adaptimmune Therapeutics (ADAP.US)$ : Approved 🎉
⇨ TECELRA (afamitresgene autoleucel)
‣ Synovial sarcoma
‣ PDUFA: 8/4/24 (BLA)
$GlaxoSmithKline (GSK.US)$ : Approved 🎉
⇨ Jemperli
‣ Endometria...

Tao Lao Zua Official

Jun 5, 2024 14:59

$Agios Pharmaceuticals (AGIO.US)$
HOW MANY STUPID TRADERS HERE, LOSING AND STILL TRADING 🤔🤔🤔

Tao Lao Zua Official

May 28, 2024 13:24

$Agios Pharmaceuticals (AGIO.US)$
Bad Demon Trap = Xi Zor Gai 😏

Meltyy

May 12, 2024 21:23

🎯 Ph 3 readouts in Q2 2024...

$United Therapeutics (UTHR.US)$ Phase 3
$Ironwood Pharmaceuticals (IRWD.US)$ Phase 3
$Liquidia (LQDA.US)$ Phase 3
$United Therapeutics (UTHR.US)$ Phase 3
$MorphoSys (MOR.US)$ Phase 3
$Immunocore (IMCR.US)$ Phase 3
$Crinetics (CRNX.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$Capricor Therapeutics (CAPR.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3...

Moomoo AI

Dec 5, 2023 11:33

Despite the recent upturn, the company’s financial performance is seen as too risky due to its sustained revenue decline and loss-making status.

Strong Week for Agios Pharmaceuticals (NASDAQ:AGIO) Shareholders Doesn't Alleviate Pain of Five-year Loss

Moomoo AI

Nov 4, 2023 07:34

Analysts are more optimistic about the company's revenue while expecting losses per share stability. They predict Agios Pharmaceuticals' growth to outpace competitors for now, despite a range of varied future estimates.

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

GemHunter

Nov 2, 2023 09:21

Loading up my bags

$Agios Pharmaceuticals (AGIO.US)$

Moomoo AI

Oct 28, 2023 08:39

Lack of insider buying and substantial insider selling in recent months warrants caution for shareholders regarding the company's stocks. Despite decent insider ownership, the absence of recent insider buying raises doubts about future prospects.

Several Agios Pharmaceuticals Insiders Sell Shares Sending Potential Negative Signal

Moomoo Breakfast US

Sep 19, 2022 07:22

Columns Today's Pre-Market Stock Movers: TTWO, AZO, BLUE, PRPL and More

Gapping up
In reaction to earnings/guidance:
• $AutoZone (AZO.US)$ +2.7%, $Jacobs Engineering (J.US)$ +0.9% (reaffirms Q4 EPS and adjusted EBITDA guidance)
Other news:
• $Purple Innovation (PRPL.US)$ +32.6% (confirms it received an unsolicited, non-binding proposal from Coliseum Capital Management to acquire all of the outstanding capital stock of Purple for $4.35 per share)
• $KnowBe4 (KNBE.US)$ +24.9% (received a non-binding proposal f...

Moomoo Breakfast US

Aug 19, 2022 07:53

Columns Today's Pre-Market Stock Movers: FL, DE, BBBY, AMC and More

Gainers:
In reaction to earnings/guidance:
• $Foot Locker (FL.US)$ +19.7%, $BILL Holdings (BILL.US)$ +18.1% (also names new COO), $Buckle Inc (BKE.US)$ +1.7%
Other news:
• $Axsome Therapeutics (AXSM.US)$ +33.8% (announces FDA approval of AUVELITY the first and only oral nmda receptor antagonist for the treatment of major depressive disorder in adults)
• $SpringWorks Therapeutics (SWTX.US)$ +4.9% (late-breaking oral presentation of phase 3 DeFi da...

No comment yet